Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $446.4 million specializing in mRNA therapeutics and vaccines, stands at a ...

Shares of card lender Synchrony Financial were down sharply following its earnings report on Tuesday. The company told analysts that “customers remain selective in their spending behavior.” Synchrony ...

Baird analyst Wesley Golladay increased the price target on Equity LifeStyle Properties (NYSE:ELS) to $73.00, up from the ...

KeyBanc Capital Markets highlights top semiconductor stocks for 2025, including Nvidia, Arm Holdings, and Applied Materials, ...